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The pathogenesis of acute coronary syndromes
(ACS) includes the rupture or erosion of a coronary
atherosclerotic plaque with variable degrees of
superimposed platelet aggregation inducing a throm-
bus [1]. ST-elevation myocardial infarction (STEMI)
is often caused by a total coronary occlusion of the
atherothrombotic plaque, whereas in non-ST-eleva-
tion myocardial infarction (NSTEMI) the thrombus is
mainly nonocclusive or transient occlusive causing
less myocardial damage [2]. Conventional percuta-
neous coronary intervention (PCI) focuses on com-
pressing the atherothrombotic plaque with the aim to
normalize ﬂow in the coronary artery and therefore
restore perfusion of the ischemic myocardium [3].
However, embolization of atherothrombotic material
may occur spontaneously after plaque rupture or due
to mechanical crushing of the culprit lesion during
PCI [4]. This results in obstruction of distal vessels or
the microcirculation in the down-stream bed of the
ischemia-related artery. Although normal epicardial
ﬂow may be achieved, this will lead to diminished
myocardial perfusion, which is associated with larger
infarct size, diminished left ventricular ejection
fraction and increased mortality [5]. Microvascular
obstruction is frequently implicated as the underlying
cause through the mechanism of embolization [6–8].
Distal protection devices (DPDs) can be used for
transient distal balloon occlusion during PCI, and
allow recovery of any liberated plaque by aspiration
before restoration of the antegrade ﬂow [9]. Whether
myocardial function can be improved with DPDs
compared with conventional PCI in patients with
acute myocardial infarction (AMI) has still to be
proven. Over the years, echocardiography [10–13]
and CMR [14–37] have found a ﬁxed niche in the
setting of AMI. In particular CMR allows the
visualization of infarct site and size whereby the iden-
tiﬁcation of microvascular obstruction has become
unique to CMR [38–40].
For echocardiography, there are limited data
describing changes in cardiac function in DPDs
studies, and no data describing changes in regional
myocardial function. Tissue Doppler imaging (TDI)
is a useful echocardiographic tool that permits
quantitative and objective assessment of both global
and regional function [41–43].
In the current issue of the International Journal of
Cardiovascular Imaging, Duan et al. [44] assessed the
effects of DPDs on global and regional LV systolic
and diastolic function were assessed by TDI in
69 patients with anterior AMI, who were ran-
domly assigned to either PCI with DPDs (DPD group,
n = 46) or conventional PCI (control group, n = 50).
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a higher LV ejection fraction than the control group.
Moreover, peak systolic and early diastolic mitral
annular velocities obtained by TDI were signiﬁcantly
higher in the DPD group than in the control group.
Lastly, the systolic and diastolic regional myocardial
velocities were signiﬁcantly improved in the DPD
group compared to the control group. The authors
concluded that patients with DPDs showed signiﬁcant
improvement of LV function. Especially patients with
anterior AMI may beneﬁt from DPDs during PCI.
In recent years various distal protection devices
and thrombectomy devices have been developed to
protect the microcirculation against embolization of
atherothrombotic material and to improve myocar-
dial reperfusion and LV function after PCI [45]. As
the use of distal protection devices is still under
debate, several trials in patients with STEMI have
recently focused on thrombus aspiration [46–49].
These trials have clearly shown that thrombus
aspiration improves myocardial reperfusion com-
pared to conventional PCI. The largest study to date,
the TAPAS-trial, showed that manual thrombus
aspiration using the Export Aspiration Catheter
(EAC) in patients with STEMI improves myocardial
perfusion and one-year clinical outcome compared
to conventional PCI [47]. As a consequence,
thrombus aspiration has been included in the new
European guidelines for patients with STEMI as a
therapy to improve myocardial perfusion [50]. To
conclude, the study of Duan et al. [44] lends support
to the notion that distal protection may be beneﬁcial
in patients with STEMI.
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